Streetbeat News

Stock Prices

LCID

Lucid Group shares are trading lower due to a downturn in the electric vehicle (EV) sector, triggered by Tesla's recently reported delivery figures.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 7:44 pm

DIS

Rosenblatt analyst Barton Crockett maintains a Buy rating on Walt Disney (DIS) and raises the price target from $129 to $137.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 7:43 pm

BTCUSD

Bitcoin has seen significant growth, rallying over 55% since the year's start and nearly 135% over the past year, driven by the approval of spot Bitcoin ETFs and anticipation of the upcoming halving event. Anthony Pompliano of Pomp Investments highlighted Bitcoin's recent milestones and predicted a potential 300% rally post-halving, attributing the surge to a combination of demand shock and upcoming supply shock. He also discussed Bitcoin as an inflation hedge and a forward-looking asset, especially in the context of rising inflation and the asset's performance against the US dollar.

Portfolio Pulse from Adam Eckert

April 02, 2024 | 7:39 pm

TKO

TKO Group shares surged following the announcement that Endeavor Group Holdings, its majority owner, has agreed to be acquired by Silver Lake.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 7:35 pm

MQ

Marqeta's stock price increased following an initiation of coverage by Monness, Crespi, Hardt with a Buy rating and a $7.50 price target.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 7:35 pm

UPS

United Parcel Service (NYSE:UPS) has seen significant options trading activity, with a bullish sentiment from the majority of trades. The trading range for UPS is projected between $130.0 to $160.0 over the next three months. The largest trades include both bullish and bearish sentiments, with the most notable being a bullish call sweep for a strike price of $160.00 expiring on 05/17/24. UPS is exploring strategic alternatives for its truck brokerage unit, Coyote. The stock is currently up 0.98% at $149.06, with analysts giving mixed ratings and target prices ranging from $100 to $165.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 7:31 pm

BEAM

Beam Therapeutics' stock is trading lower following an announcement by Verve Therapeutics that it has paused enrollment in its Heart-1 clinical trial. This development is significant due to a prior license agreement between Verve and Beam, granting Verve access to Beam's base editing, gene editing, and delivery technologies.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 7:30 pm

CDW

CDW (NASDAQ:CDW) has significantly outperformed the market with an average annual return of 24.83% over the past 10 years, turning a $100 investment into $912.01 today. The company's market capitalization stands at $33.68 billion.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 7:30 pm

CVE

Cenovus Energy (NYSE:CVE) has delivered an average annual return of 16.2% over the past 5 years, outperforming the market by 3.81% on an annualized basis. A $1000 investment in CVE 5 years ago would now be worth $2,175.19, showcasing the impact of compounded returns on investment growth. Cenovus Energy currently has a market capitalization of $37.78 billion.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 7:30 pm

RH

RH shares are trading lower due to a general downturn in the consumer discretionary sector.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 7:29 pm